These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Inhibition of growth factor-induced Ras signaling in vascular endothelial cells and angiogenesis by 3,3'-diindolylmethane. Chang X; Firestone GL; Bjeldanes LF Carcinogenesis; 2006 Mar; 27(3):541-50. PubMed ID: 16199440 [TBL] [Abstract][Full Text] [Related]
13. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair. Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600 [TBL] [Abstract][Full Text] [Related]
14. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis. Kou B; Ni J; Vatish M; Singer DR Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220 [TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways. Sun C; Liang C; Ren Y; Zhen Y; He Z; Wang H; Tan H; Pan X; Wu Z Basic Res Cardiol; 2009 Jan; 104(1):42-9. PubMed ID: 18622638 [TBL] [Abstract][Full Text] [Related]
16. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Tchaikovski V; Fellbrich G; Waltenberger J Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):322-8. PubMed ID: 18079407 [TBL] [Abstract][Full Text] [Related]
17. Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. Sasso FC; Torella D; Carbonara O; Ellison GM; Torella M; Scardone M; Marra C; Nasti R; Marfella R; Cozzolino D; Indolfi C; Cotrufo M; Torella R; Salvatore T J Am Coll Cardiol; 2005 Sep; 46(5):827-34. PubMed ID: 16139132 [TBL] [Abstract][Full Text] [Related]
18. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells. Caron C; Spring K; Laramée M; Chabot C; Cloutier M; Gu H; Royal I Cell Signal; 2009 Jun; 21(6):943-53. PubMed ID: 19233262 [TBL] [Abstract][Full Text] [Related]
19. New molecular mechanisms of the unexpectedly complex role of VEGF in ulcerative colitis. Tolstanova G; Khomenko T; Deng X; Szabo S; Sandor Z Biochem Biophys Res Commun; 2010 Sep; 399(4):613-6. PubMed ID: 20682292 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation. Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]